PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-31.01%
Both yoy net incomes decline, with CNQ at -18.68%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-23.63%
Both reduce yoy D&A, with CNQ at -25.70%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-26.56%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
253.33%
SBC growth well above CNQ's 6.06%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-35.14%
Negative yoy working capital usage while CNQ is 100.89%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-34.13%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
19.05%
Inventory growth of 19.05% while CNQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
44.37%
AP growth of 44.37% while CNQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-35.14%
Negative yoy usage while CNQ is 100.89%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
124.07%
Well above CNQ's 138.12%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-22.19%
Negative yoy CFO while CNQ is 111.97%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-4.92%
Both yoy lines negative, with CNQ at -27.10%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1249.20%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
334.85%
We have some outflow growth while CNQ is negative at -97.37%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-248.55%
Both yoy lines negative, with CNQ at -35.30%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
98.59%
Debt repayment above 1.5x CNQ's 12.82%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
62.76%
Repurchase growth above 1.5x CNQ's 28.47%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.